Bi-213-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience - Kratochwil, Clemens; Giesel, Frederik L.; Mier, Walter; Haberkorn, Uwe (European journal of nuclear medicine and molecular imaging, 2014)
Gesehen am 11.02.2016